| Unique ID issued by UMIN | UMIN000054438 |
|---|---|
| Receipt number | R000058272 |
| Scientific Title | A pilot study of Pharmacist-Dietician Collaborative support and Advice (PDCA) for patients with hypertension in community pharmacy: A single-arm, pre-post study |
| Date of disclosure of the study information | 2024/08/31 |
| Last modified on | 2025/04/18 15:49:53 |
A pilot study of Pharmacist-Dietician Collaborative support and Advice (PDCA) for patients with hypertension in community pharmacy: A single-arm, pre-post study
PDCA-hypertension Study
A pilot study of Pharmacist-Dietician Collaborative support and Advice (PDCA) for patients with hypertension in community pharmacy: A single-arm, pre-post study
PDCA-hypertension Study
| Japan |
hypertension
| Medicine in general | Cardiology |
Others
NO
Evaluation of the Effectiveness of Collaboration between Pharmacy Nutritionists and Pharmacists in Supporting Dietary Habit Improvement for Patients with Hypertension
Efficacy
Confirmatory
Pragmatic
Not applicable
Systolic and diastolic blood pressure
Salt intake, DASH diet intake, degree of exercise habits, degree of alcohol consumption, Body Mass Index (BMI), medication adherence, and satisfaction with pharmacy services.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
YES
1
Educational,Counseling,Training
| Behavior,custom |
A dietitian working in the pharmacy collaborates with the pharmacist to provide dietary guidance after medication instruction.
| 20 | years-old | <= |
| 75 | years-old | >= |
Male and Female
Patients with essential hypertension who have been taking blood pressure-lowering medication for at least one month and are expected to visit the pharmacy where the interventionist works on a regular basis
Systolic blood pressure greater than 140 mmHg or diastolic blood pressure greater than 90 mmHg
1. patients who have difficulty in measuring blood pressure (dementia, taking antipsychotics or antidepressants, etc.)
2. patients undergoing treatment for diseases that may cause weight changes (malignant tumors, hypopituitarism, hyperthyroidism, gastric ulcer, etc.)
3. those who are already on a diet (e.g., those who are instructed by a physician to follow a special diet, those who are receiving private dietary support services, etc.)
4. other persons who are considered to have difficulty participating in the intervention study.
20
| 1st name | Masaki |
| Middle name | |
| Last name | Shoji |
Osaka Medical and Pharmaceutical University
Department of Social and Administrative Pharmacy
569-1094
4-20-1, Nasahara, Takatsuki city, Osaka
072-690-1059
masaki.shoji@ompu.ac.jp
| 1st name | Masaki |
| Middle name | |
| Last name | Shoji |
Osaka Medical and Pharmaceutical University
Department of Social and Administrative Pharmacy
569-1094
4-20-1, Nasahara, Takatsuki city, Osaka
0726831221
masaki.shoji@ompu.ac.jp
Osaka Medical and Pharmaceutical University
None
Self funding
Osaka Medical and Pharmaceutical University study ethical committee
2-7, Daigakucho, Takatsuki city, Osaka
072-683-1221
rinri@ompu.ac.jp
NO
| 2024 | Year | 08 | Month | 31 | Day |
Unpublished
No longer recruiting
| 2024 | Year | 05 | Month | 20 | Day |
| 2024 | Year | 05 | Month | 15 | Day |
| 2024 | Year | 09 | Month | 01 | Day |
| 2025 | Year | 09 | Month | 01 | Day |
| 2024 | Year | 05 | Month | 20 | Day |
| 2025 | Year | 04 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058272